News ( Year: 2019 )

SORT BY YEAR
10 May, 2019

Ally Bridge Portfolio News – Pulmonx Closes $65 Million Financing and Adds Chief Financial Officer

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies, announced today the closing of an oversubscribed $65 million equity financing and the hiring of Derrick Sung, Ph.D. as its Chief Financial Officer. The financing was led by Ally Bridge Group, a leading global life science-dedicated investment group, and included other […]

Read More
10 May, 2019

Ally Bridge Group Leads Pulmonx’s $65 Million Financing, Further Strengthening Its Global Medtech Franchise

HONG KONG, May 9, 2019 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading global life science investment group, announced today that it led an over-subscribed $65 million financing of Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies with its key product approved and marketed in the US, Europe, Australia, and Asia, including China. Pulmonx is focused on developing life-changing technologies […]

Read More
4 April, 2019

Ally Bridge, LifeTech Scientific and Quantum Surgical Announce Three-Way China Joint Venture to Develop Innovative Surgical Robot for the Treatment of Liver Cancer

HONG KONG, SHENZHEN, China, and Montpellier, France, April 4, 2019 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading cross-border life science investment group, announced today that it has entered into an agreement with LifeTech Scientific Corporation (SEHK: 1302) (“LifeTech”), a leading medical device company in China, and Quantum Surgical, an innovative surgical robotics company in […]

Read More
8 March, 2019

Ally Bridge Portfolio News – ShockWave Medical shares soared by more than 79% in its Wall Street debut

ShockWave Medical Inc. shares soared by more than 79 percent in its Wall Street debut on Thursday after it raised nearly $97 million in an upsized IPO. The Santa Clara life sciences company sold 5.7 million shares of common stock for $17 a share. That was about 700,000 more shares than were expected to be […]

Read More
8 March, 2019

Ally Bridge Portfolio News – ShockWave Medical prices upsized IPO above the range at $17

SANTA CLARA, Calif., March 06, 2019 (GLOBE NEWSWIRE) — ShockWave Medical, Inc. (“ShockWave”) today announced the pricing of its initial public offering of 5,700,000 shares of its common stock at a price to the public of $17.00 per share. The shares are expected to begin trading on the Nasdaq Global Select Market on March 7, […]

Read More